Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
23 studies found for:    " January 18, 2012":" February 17, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Recruiting Effects of Losartan and Antiretroviral Regimen Containing Raltegravir in Fibrosis Inflammation Mediators, Cardiovascular Risk and Neurocognitive Disorders in HIV Infected Patients Previously Effectively Treated
Condition: HIV-1
Interventions: Drug: EFV/FTC/TDF + Losartan;   Drug: EFV/FTC/TDF;   Drug: FTC/TDF + MK-0518;   Drug: FTC/TDF+MK-0518+Losartan
22 Completed
Has Results
Intervention to Retain HIV-positive Patients in Medical Care
Condition: Primary Care Appointment Keeping
Interventions: Behavioral: Enhanced contact plus behavioral skills;   Behavioral: Enhanced contact only;   Behavioral: Standard of Care
23 Active, not recruiting Operational Research for Cryptococcal Antigen Screening
Conditions: Cryptococcal Meningitis;   Cryptococcus Neoformans;   Cryptococcosis
Intervention: Drug: Fluconazole

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-23) Next Page   
Indicates status has not been verified in more than two years